Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

American Health Imaging US Radiology Specialists

US Radiology Specialists affiliate expands into new market

Atlanta-based American Health Imaging is opening two new multimodality imaging centers around Alabama's most populous city. 

insurance insurer payment claim denial reimbursement prior authorization

Radiologist rails against insurer’s refusal to cover key interventional service

Michael Ginsburg, MD, shared his frustrations on social media after Cigna declined to reimburse for a prostate artery embolization procedure. 

Edwards Evoque transcatheter tricuspid valve replacement TTVR

CMS proposes Medicare coverage for transcatheter tricuspid valve replacement

Edwards Lifesciences sent a formal request to CMS in February after its Evoque TTVR device gained FDA approval. The agency is now accepting public comments for 30 days.

Blue Cross Blue Shield BCBS

Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

The BCBS decision pertains to gadopiclenol, a gadolinium-based product sold under the brand names Elucirem and Vueway. 

Medicare Medicaid reimbursement

Radiology experts say state Medicaid rates must increase to improve imaging access

Eliminating reimbursement gaps may reduce the healthcare and outcome disparities experienced by these underserved groups, ACR-affiliated researchers reported. 

Video of SNMMI President Cathy Cutler explaining advocacy efforts for nuclear imaging. #SNMMI

Policy reforms in Washington that will impact nuclear imaging

SNMMI President Cathy Cutler, PhD, explains some of the key policy initiatives the society is pursuing to help support the field of nuclear medicine. 

healthcare value value-based care money dollar

Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

BioZorb 3D bioabsorbable marker Hologic

Hologic recalling breast care device after 252 injuries, slew of patient lawsuits

More than 100 plaintiffs have now sued the Marlborough, Massachusetts-based mammography-maker, claiming they suffered injuries and emotional distress stemming from implantation of the BioZorb radiographic marker.